Concepedia

Annie Nikolajsen

AN

Statistics

Publications

10

Citations

441

H-Index

10

Active since

2014

Affiliations

Novo Nordisk (Denmark)(Current)

Brod Group

Novo Nordisk (United States)

Annie Nikolajsen is an author at Novo Nordisk (Denmark) specializing in diabetes mellitus, insulin therapy, and internal medicine.

ORCID

Publications per year

2014–2017

10

Publications

10

Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin

Kamlesh Khunti, Annie Nikolajsen, Brian Larsen Thorsted et al. · Diabetes Obesity and Metabolism · 2016 · 253 citations · Full text

, , +17

Timing of Insulin Injections, Adherence, and Glycemic Control in a Multinational Sample of People with Type 2 Diabetes: A Cross-Sectional Analysis

Nicolaas C. Schaper, Annie Nikolajsen, Anna Sandberg et al. · Diabetes Therapy · 2017 · 28 citations · Full text

, , +16

An analysis of the cost-effectiveness of switching from biphasic human insulin 30, insulin glargine, or neutral protamine Hagedorn to biphasic insulin aspart 30 in people with type 2 diabetes

Vishal Gupta, Ranya Baabbad, E. Hammerby et al. · Journal of Medical Economics · 2014 · 24 citations

, , +17

Patients' with type 2 diabetes willingness to pay for insulin therapy and clinical outcomes

Michael Feher, John Brazier, Nicolaas C. Schaper et al. · BMJ Open Diabetes Research & Care · 2016 · 24 citations · Full text

, , +17

An analysis of the cost-effectiveness of starting insulin detemir in insulin-naïve people with type 2 diabetes

Philip Home, Sei Hyun Baik, Guillermo González-Gálvez et al. · Journal of Medical Economics · 2014 · 23 citations · Full text

, , +17

1–5 of 10